University of Massachusetts, Worcester
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Massachusetts, Worcester sits in the top decile of US sponsors by registered trial count (#136 of 15,742 sponsors by registered trial count).
University of Massachusetts, Worcester: 240 sponsored US clinical trials, 30 recruiting.
University of Massachusetts, Worcester sponsors 240 registered US clinical trials on ClinicalTrials.gov, 30 of them currently recruiting, and 177 completed. 23 of these trials are in Phase 3-4 (later-stage) and 38 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alcohol Use Disorder, with 4 trials.
Top-decile sponsor footprint
University of Massachusetts, Worcester ranks in the top decile of sponsors by registered trial count (#136 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
177 of 191 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
240 total, page 2 of 5
FIT-COACH: Fitbit Intervention With Coordinated Health Coaching and PCP Support
NCT06915090
Responses to E-cigarette Message Source and Presentation
NCT06274723
A Text Messaging Intervention to Reduce Perinatal Depression Risk
NCT06117397
A Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer's Disease: Implementation Phase 2
NCT06368115
Music Therapy to Prevent Hospital-acquired Delirium in Parkinson's Disease and Dementia With Lewy Bodies
NCT06063161
Continuous Glucose Monitoring in the Intensive Care Unit
NCT06190808
Responses to Message Source and Presentation Using Psychophysiology
NCT06269003
Feasibility Study of Use and Acceptability of New Clear Communication of Lab Test Results (CCLR) Letter for Older Adults
NCT06971887
Tele-Navigation of Lung Cancer Screening (Tele-Navi LCS)
NCT05021133
COVIDVaxStories: Randomized Trial to Reduce COVID-19 Vaccine Hesitancy in Populations of Color
NCT06297876
Sign Here: How to Conduct Informed Consent With Deaf Individuals
NCT05268055
CT C-spine Audit and Feedback
NCT05711134
A Multicomponent Clinic-based Intervention to Promote COVID-19 Vaccine Intention and Uptake Among Diverse Youth and Adolescents
NCT05722652
Survivor mHealth: Wearable Devices in Cancer Survivors
NCT05417438
Vaper to Vaper: A Multimodal Mobile Peer Driven Intervention to Support Adolescents in Quitting Vaping
NCT05140915
Healthy At Home Pilot
NCT06000696
Trusted Messengers: Intervention to Promote COVID-19 Vaccination
NCT04981392
A Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer's Disease
NCT05147428
Responses to Regulated E-Cigarette Advertisements
NCT05207033
Technology-Assisted Systems Change for Suicide Prevention
NCT04720911
Use of a Sleep System to Improve Sleep
NCT05175456
Pilot Randomized Controlled Study of the Impact of MedRhythms' MR-010 in Acute Stroke
NCT04689256
Online Training for Addressing Perinatal Depression
NCT04919967
Asthma Link: A Real World Application of School Supervised Asthma Therapy
NCT04942379
Responses to E-Cigarette Advertising
NCT04249219
Post-Operative Urinary Retention (POUR) in Thoracic Surgery Patients Receiving Prophylactic Tamsulosin
NCT04994431
Telehealth to Improve Prevention of Suicide (TIPS)
NCT04800029
Adapt2Quit - An Adaptive Motivational System for Socio-Economically Disadvantaged Smokers
NCT04720625
Study of Clinic-delivered Physical Activity Referrals to Cancer Survivors
NCT05216380
Dotarem vs Gadobutrol Contrast for Breast MRI
NCT03730051
Assessing Visual Processing in High Anxiety
NCT04187326
Group intEgrative MINdfulness Over the Internet Using an Online Platform
NCT04340739
Impact of Wearable Health Devices and Wellness Behavior Change Support on Health Outcomes and Healthcare Costs
NCT04712383
Views on COVID-19 and Vaccination
NCT04706403
Comparison of Quadratus Lumborum Block Types
NCT04588389
New Skills - No Scores Research Study
NCT04254666
Standardized Patient-Centered Medication Review in Home Hospice
NCT03972163
Speech, Linguistic and Acoustic Markers in Parkinson's Disease
NCT04273672
Comparison of Non-invasive and Invasive Blood Pressure Monitors
NCT04506775
LEAVE Safe With DOACs
NCT04068727
Shared Decision-Making: AFib 2gether Mobile App
NCT04118270
Helping Youth on the Path to Employment
NCT04254562
Implementing an Intervention to Address Social Determinants of Health in Pediatric Practices
NCT02918435
Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke
NCT03761394
Wildlife and Wellbeing: An Animal-Assisted Intervention for Veterans With PTSD
NCT04116489
Piloting "Signs of Safety": A Deaf-Accessible Therapy Toolkit for Alcohol Use Disorder and Trauma
NCT03845985
Timing For Single View Bedside Cardiac Ultrasound
NCT03927755
Web-based Visit for Colorectal Surgery
NCT05084131
Effect of Preoperative Fiber on Postoperative Bowel Function
NCT04882995
Older Adult Safety in Surgery IV (OASIS)
NCT03892187
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 24 |
| Phase 2 | 14 |
| Phase 3 | 11 |
| Phase 4 | 12 |
Therapeutic Areas
What is open in the University of Massachusetts, Worcester pipeline
30 recruiting of 240 indexed (13% open); 177 completed (74%).
Phase mix: 23 late (III/IV) vs 38 early (I/II) (early-phase heavy).
Top condition: Alcohol Use Disorder (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Massachusetts, Worcester: open-pipeline peers nationwide
Peers matched on 240 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Massachusetts, Worcester sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 240 trials (± recruiting share)
- Incyte Corporation · 239 trials · 15% recruiting
- State University of New York at Buffalo · 243 trials · 21% recruiting
- Loma Linda University · 237 trials · 15% recruiting
- Daiichi Sankyo · 236 trials · 12% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Addario Lung Cancer Medical Institute · 13% recruiting · 8 trials
- American University · 13% recruiting · 16 trials
- Annexon · 13% recruiting · 8 trials
- Ansun Biopharma · 13% recruiting · 8 trials
Related
What to do with this University of Massachusetts, Worcester page
240 registered trials is a research-attention snapshot, not an endorsement of University of Massachusetts, Worcester or any single study.
- 30 of University of Massachusetts, Worcester's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alcohol Use Disorder is the condition University of Massachusetts, Worcester studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alcohol Use Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Massachusetts, Worcester pipeline card: 240 registered trials from official public datasets.Report a data error.